शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ZOTANSEZOTA HEALTH CARE LIMITED· Pharmaceuticals & BiotechnologyHighPositive
Announced Mon, 28 Sept, 2026 · 13:16 IST

Zota Health Care 26th AGM: Re.1 Dividend, Director Appointments Approved

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.8%Reaction day
₹1344.80
prior close
₹1311.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-0.2% vs market
Pharmaceuticals peers, median of 172sector-1.5%-0.3% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.3
15m
+0.7
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.8-1.6-0.2-1.5-0.3
Next day
-4.0-0.6-3.4-1.0-3.0
2d
-3.0-0.8-2.1-1.9-1.1
3d
-6.8-2.1-4.7-2.4-4.4
4d
-4.4-2.1-2.3-3.2-1.2
5d
-4.8-0.8-4.0-2.4-2.5
1w
-1.5-3.8+2.3-4.3+2.8
15d
-2.3-6.9+4.6-7.9+5.6
1m
-5.6-8.0+2.4-6.6+1.0
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zota Health Care held its 26th AGM on Sept 28, 2026 via video conferencing. Members approved audited FY26 financial statements, a final dividend of 10 percent (Re.1 per share) for FY26, re-appointment of Whole-time Director, appointment of new Independent Director, and re-appointment of Managing Director. Related party transactions with subsidiary Everyday Herbal Beauty Care were also approved. Presentation showed retail pharmacy chain revenue growing to 77 percent of total, with 2,579 Davaindia stores across 23 states.

Likely market impact

Confirms Re.1 per share dividend for FY26. Retail pharmacy now 77 percent of revenue with 2,579 stores, showing strong business shift to Davaindia.